{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:13:03Z","timestamp":1787940783246,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,7]]},"DOI":"10.7759\/cureus.94003","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:30:11Z","timestamp":1759825811000},"source":"Crossref","is-referenced-by-count":1,"title":["Use of Human Chorionic Gonadotropin (HCG) or HCG-Combined Treatments in Male Infertility: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Haris","family":"Shoaib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.04.048","article-title":"European Association of Urology guidelines on male infertility: the 2012 update","volume":"62","author":"Jungwirth A","year":"2012","unstructured":"Jungwirth A, Giwercman A, Tournaye H, Diemer T, Kopa Z, Dohle G, Krausz C. European Association of Urology guidelines on male infertility: the 2012 update. Eur Urol. 2012, 62:324-32. 10.1016\/j.eururo.2012.04.048","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2016.08.018","article-title":"Semen proteomics and male infertility","volume":"162","author":"Jodar M","year":"2017","unstructured":"Jodar M, Soler-Ventura A, Oliva R. Semen proteomics and male infertility. J Proteomics. 2017, 162:125-34. 10.1016\/j.jprot.2016.08.018","journal-title":"J Proteomics"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.179252","article-title":"Current medical management of endocrine-related male infertility","volume":"18","author":"Ring JD","year":"2016","unstructured":"Ring JD, Lwin AA, K\u00f6hler TS. Current medical management of endocrine-related male infertility. Asian J Androl. 2016, 18:357-63. 10.4103\/1008-682X.179252","journal-title":"Asian J Androl"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-1-3","article-title":"Clinical review 4: diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men","volume":"70","author":"Whitcomb RW","year":"1990","unstructured":"Whitcomb RW, Crowley WF Jr. Clinical review 4: diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men. J Clin Endocrinol Metab. 1990, 70:3-7. 10.1210\/jcem-70-1-3","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0303-7207(99)00227-0","article-title":"Hormone substitution in male hypogonadism","volume":"161","author":"Zitzmann M","year":"2000","unstructured":"Zitzmann M, Nieschlag E. Hormone substitution in male hypogonadism. Mol Cell Endocrinol. 2000, 161:73-88. 10.1016\/s0303-7207(99)00227-0","journal-title":"Mol Cell Endocrinol"},{"key":"ref6","article-title":"Comparison of recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial","volume":"10","author":"Amirzargar MA","year":"2012","unstructured":"Amirzargar MA, Yavangi M, Basiri A, et al.. Comparison of recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial. Iran J Reprod Med. 2012, 10:441-52.","journal-title":"Iran J Reprod Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.10.052","article-title":"The treatment of hypogonadism in\u00a0men of reproductive age","volume":"99","author":"Kim ED","year":"2013","unstructured":"Kim ED, Crosnoe L, Bar-Chama N, Khera M, Lipshultz LI. The treatment of hypogonadism in\u00a0men of reproductive age. Fertil Steril. 2013, 99:718-24. 10.1016\/j.fertnstert.2012.10.052","journal-title":"Fertil Steril"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-009-0203-1","article-title":"Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism","volume":"13","author":"Farhat R","year":"2010","unstructured":"Farhat R, Al-zidjali F, Alzahrani AS. Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism. Pituitary. 2010, 13:105-10. 10.1007\/s11102-009-0203-1","journal-title":"Pituitary"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1984.tb38305.x","article-title":"Therapeutic considerations and results of gonadotropin treatment in male hypogonadotropic hypogonadism","volume":"438","author":"Burger HG","year":"1984","unstructured":"Burger HG, Baker HW. Therapeutic considerations and results of gonadotropin treatment in male hypogonadotropic hypogonadism. Ann N Y Acad Sci. 1984, 438:447-53. 10.1111\/j.1749-6632.1984.tb38305.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.1992.tb01131.x","article-title":"Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism - long-term follow-up","volume":"15","author":"Vicari E","year":"1992","unstructured":"Vicari E, Mongio\u00ec A, Calogero AE, Moncada ML, Sidoti G, Polosa P, D'Agata R. Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism - long-term follow-up. Int J Androl. 1992, 15:320-9. 10.1111\/j.1365-2605.1992.tb01131.x","journal-title":"Int J Androl"},{"key":"ref11","article-title":"Treatment of male infertility","volume":"34","author":"Check JH","year":"2007","unstructured":"Check JH. Treatment of male infertility. Clin Exp Obstet Gynecol. 2007, 34:201-6.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000001231","article-title":"Medical therapy for male infertility","volume":"35","author":"Pozzi E","year":"2025","unstructured":"Pozzi E, Corsini C, Salonia A. Medical therapy for male infertility. Curr Opin Urol. 2025, 35:157-64. 10.1097\/MOU.0000000000001231","journal-title":"Curr Opin Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15151","article-title":"Efficacy of gonadotropin treatment for Induction of spermatogenesis in men with pathologic gonadotropin deficiency: a meta-analysis","volume":"102","author":"Muir CA","year":"2025","unstructured":"Muir CA, Zhang T, Jayadev V, Conway AJ, Handelsman DJ. Efficacy of gonadotropin treatment for Induction of spermatogenesis in men with pathologic gonadotropin deficiency: a meta-analysis. Clin Endocrinol (Oxf). 2025, 102:167-77. 10.1111\/cen.15151","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad AR","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996, 17:1-12. 10.1016\/0197-2456(95)00134-4","journal-title":"Control Clin Trials"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.2003.tb02712.x","article-title":"Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone","volume":"24","author":"Bouloux PM","year":"2003","unstructured":"Bouloux PM, Nieschlag E, Burger HG, et al.. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl. 2003, 24:604-11. 10.1002\/j.1939-4640.2003.tb02712.x","journal-title":"J Androl"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14401","article-title":"Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study","volume":"122","author":"Habous M","year":"2018","unstructured":"Habous M, Giona S, Tealab A, et al.. Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study. BJU Int. 2018, 122:889-97. 10.1111\/bju.14401","journal-title":"BJU Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-6-1081","article-title":"Treatment of severe oligospermia with human chorionic gonadotropin\/human menopausal gonadotropin: a placebo-controlled, double blind trial","volume":"65","author":"Knuth UA","year":"1987","unstructured":"Knuth UA, H\u00f6nigl W, Bals-Pratsch M, Schleicher G, Nieschlag E. Treatment of severe oligospermia with human chorionic gonadotropin\/human menopausal gonadotropin: a placebo-controlled, double blind trial. J Clin Endocrinol Metab. 1987, 65:1081-7. 10.1210\/jcem-65-6-1081","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/13685538.2015.1092021","article-title":"Late-onset hypogonadism: the advantages of treatment with human chorionic gonadotropin rather than testosterone","volume":"19","author":"La Vignera S","year":"2016","unstructured":"La Vignera S, Condorelli RA, Cimino L, Russo GI, Morgia G, Calogero AE. Late-onset hypogonadism: the advantages of treatment with human chorionic gonadotropin rather than testosterone. Aging Male. 2016, 19:34-9. 10.3109\/13685538.2015.1092021","journal-title":"Aging Male"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/and.13271","article-title":"Treatment of idiopathic oligozoospermia with combined human chorionic gonadotropin\/human menopausal gonadotrophin: a randomised, double-blinded, placebo-controlled clinical study","volume":"51","author":"Zhao N","year":"2019","unstructured":"Zhao N, Lu XL, Li JT, Zhang JM. Treatment of idiopathic oligozoospermia with combined human chorionic gonadotropin\/human menopausal gonadotrophin: a randomised, double-blinded, placebo-controlled clinical study. Andrologia. 2019, 51:e13271. 10.1111\/and.13271","journal-title":"Andrologia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.07.1766","article-title":"Gonadotropin administration after gonadotropin-releasing-hormone agonist: a therapeutic option in severe testiculopathies","volume":"92","author":"Foresta C","year":"2009","unstructured":"Foresta C, Selice R, Moretti A, Pati MA, Carraro M, Engl B, Garolla A. Gonadotropin administration after gonadotropin-releasing-hormone agonist: a therapeutic option in severe testiculopathies. Fertil Steril. 2009, 92:1326-32. 10.1016\/j.fertnstert.2008.07.1766","journal-title":"Fertil Steril"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoy007","article-title":"A protocol developing, disseminating and implementing a core outcome set for infertility","volume":"2018","author":"Duffy JM","year":"2018","unstructured":"Duffy JM, Bhattacharya S, Curtis C, et al.. A protocol developing, disseminating and implementing a core outcome set for infertility. Hum Reprod Open. 2018, 2018:hoy007. 10.1093\/hropen\/hoy007","journal-title":"Hum Reprod Open"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2018.04.03","article-title":"Frontiers in hormone therapy for male infertility","volume":"7","author":"Khourdaji I","year":"2018","unstructured":"Khourdaji I, Lee H, Smith RP. Frontiers in hormone therapy for male infertility. Transl Androl Urol. 2018, 7:S353-66. 10.21037\/tau.2018.04.03","journal-title":"Transl Androl Urol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.3.596","article-title":"Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial","volume":"13","author":"Kamischke A","year":"1998","unstructured":"Kamischke A, Behre HM, Bergmann M, Simoni M, Sch\u00e4fer T, Nieschlag E. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod. 1998, 13:596-603. 10.1093\/humrep\/13.3.596","journal-title":"Hum Reprod"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-15-0124","article-title":"Successful fertility treatment with gonadotrophin therapy for male hypogonadotrophic hypogonadism","volume":"2016","author":"Rajkanna J","year":"2016","unstructured":"Rajkanna J, Tariq S, Oyibo SO. Successful fertility treatment with gonadotrophin therapy for male hypogonadotrophic hypogonadism. Endocrinol Diabetes Metab Case Rep. 2016, 2016:150124. 10.1530\/EDM-15-0124","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0449","article-title":"Restoration of fertility by gonadotropin replacement in a man with hypogonadotropic azoospermia and testicular adrenal rest tumors due to untreated simple virilizing congenital adrenal hyperplasia","volume":"170","author":"Rohayem J","year":"2014","unstructured":"Rohayem J, T\u00fcttelmann F, Mallidis C, Nieschlag E, Kliesch S, Zitzmann M. Restoration of fertility by gonadotropin replacement in a man with hypogonadotropic azoospermia and testicular adrenal rest tumors due to untreated simple virilizing congenital adrenal hyperplasia. Eur J Endocrinol. 2014, 170:K11-17. 10.1530\/EJE-13-0449","journal-title":"Eur J Endocrinol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2010.493552","article-title":"Alcohol, drugs, caffeine, tobacco, and environmental contaminant exposure: reproductive health consequences and clinical implications","volume":"40","author":"Sadeu JC","year":"2010","unstructured":"Sadeu JC, Hughes CL, Agarwal S, Foster WG. Alcohol, drugs, caffeine, tobacco, and environmental contaminant exposure: reproductive health consequences and clinical implications. Crit Rev Toxicol. 2010, 40:633-52. 10.3109\/10408444.2010.493552","journal-title":"Crit Rev Toxicol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2223-4683.2014.01.06","article-title":"Medical treatment of male infertility","volume":"3","author":"Dabaja AA","year":"2014","unstructured":"Dabaja AA, Schlegel PN. Medical treatment of male infertility. Transl Androl Urol. 2014, 3:9-16. 10.3978\/j.issn.2223-4683.2014.01.06","journal-title":"Transl Androl Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/304922-use-of-human-chorionic-gonadotropin-hcg-or-hcg-combined-treatments-in-male-infertility-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:30:13Z","timestamp":1759825813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/304922-use-of-human-chorionic-gonadotropin-hcg-or-hcg-combined-treatments-in-male-infertility-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.94003","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}